Kaka Dey, Ph.D. - Publications

Affiliations: 
2002 University of Nevada, Reno, Reno, NV, United States 
Area:
Medicinal chemistry, HIV

6 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2011 Bhattacharya S, Chakrabarty B, Kundu PK, Maji A, Ghosal SR, Dey KK. Prevalence of HIV seropositivity among surgical patients in a tertiary care hospital. Journal of the Indian Medical Association. 109: 896-8. PMID 23469570  0.375
2007 Vermeire K, Lisco A, Grivel JC, Scarbrough E, Dey K, Duffy N, Margolis L, Bell TW, Schols D. Design and cellular kinetics of dansyl-labeled CADA derivatives with anti-HIV and CD4 receptor down-modulating activity. Biochemical Pharmacology. 74: 566-78. PMID 17603023 DOI: 10.1016/J.Bcp.2007.05.018  0.734
2007 VERMEIRE K, LISCO A, GRIVEL J, BLANK P, SCHRAM V, DUFFY N, SCARBROUGH E, DEY K, BELL T, MARGOLIS L. Design and Cellular Kinetics of Dansyl-labeled CADA Derivatives with Specific Anti-HIV and CD4 Receptor Down-modulating Properties Antiviral Research. 74: A68-A69. DOI: 10.1016/J.Antiviral.2007.01.109  0.691
2006 Bell TW, Anugu S, Bailey P, Catalano VJ, Dey K, Drew MG, Duffy NH, Jin Q, Samala MF, Sodoma A, Welch WH, Schols D, Vermeire K. Synthesis and structure-activity relationship studies of CD4 down-modulating cyclotriazadisulfonamide (CADA) analogues. Journal of Medicinal Chemistry. 49: 1291-312. PMID 16480266 DOI: 10.1021/Jm0582524  0.428
2004 Vermeire K, Princen K, Hatse S, De Clercq E, Dey K, Bell TW, Schols D. CADA, a novel CD4-targeted HIV inhibitor, is synergistic with various anti-HIV drugs in vitro. Aids (London, England). 18: 2115-25. PMID 15577644 DOI: 10.1097/00002030-200411050-00003  0.651
2002 Vermeire K, Zhang Y, Princen K, Hatse S, Samala MF, Dey K, Choi HJ, Ahn Y, Sodoma A, Snoeck R, Andrei G, De Clercq E, Bell TW, Schols D. CADA inhibits human immunodeficiency virus and human herpesvirus 7 replication by down-modulation of the cellular CD4 receptor. Virology. 302: 342-53. PMID 12441078 DOI: 10.1006/Viro.2002.1624  0.667
Show low-probability matches.